Received Mar 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 5 | — | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 2 | — | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 2 | — | — |
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 3 | U7623AA | IM / RL |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 2 | Y004117 | SC / LL |
| PNC13 | PNEUMO (PREVNAR13) | PFIZER\WYETH | 4 | LJ5283 | IM / RL |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 2 | Y013350 | SC / LL |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 2 | — | OT |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 2 | — | OT |
Fever of 103+, rash, and lethargy starting the day after and lasting about 2 days. Physical exam conducted by DO in office 4 days after the vaccinations. Appt was concluded with normal neuro exam, normal motor functions, regular cardiovascular findings, and good general appearance.
none
none
none
none